LYMPHIR
Live / Applied — Third extension granted (statement of use) (as of 29 Sept 2025)
What this means for you
Not registered yet, but its 04 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97871965
- Mark type
- Stylized text
- Filed
- 04 Apr 2023
- Published for opposition
- 06 Feb 2024
- Attorney of record
- William S. Fultz
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Pharmaceutical products for the treatment of cancer
Owner
- CITIUS ONCOLOGY, INC., CRANFORD, NJ, US
- Citius Pharmaceuticals, Inc., Cranford, NJ, US
- Citius Pharmaceuticals, Inc., Cranford, NJ, US
Prosecution history
- 02 Apr 2026 — TEAS STATEMENT OF USE RECEIVED
- 30 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2025 — SOU EXTENSION 3 GRANTED
- 29 Sept 2025 — SOU EXTENSION 3 FILED
- 29 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2025 — SOU EXTENSION 2 GRANTED
- 10 Feb 2025 — SOU EXTENSION 2 FILED
- 10 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2024 — SOU EXTENSION 1 GRANTED
- 02 Oct 2024 — SOU EXTENSION 1 FILED
- 20 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Oct 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Oct 2024 — SOU TEAS EXTENSION RECEIVED